000518 Stock Overview
Engages in the pharmaceutical business in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Jiangsu Sihuan Bioengineering Co., Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥3.37 |
| 52 Week High | CN¥4.57 |
| 52 Week Low | CN¥1.72 |
| Beta | 0.52 |
| 11 Month Change | 44.64% |
| 3 Month Change | 74.61% |
| 1 Year Change | -18.80% |
| 33 Year Change | 5.31% |
| 5 Year Change | 1.51% |
| Change since IPO | 430.36% |
Recent News & Updates
Recent updates
What Jiangsu Sihuan Bioengineering Co., Ltd's (SZSE:000518) 33% Share Price Gain Is Not Telling You
Oct 28
More Unpleasant Surprises Could Be In Store For Jiangsu Sihuan Bioengineering Co., Ltd's (SZSE:000518) Shares After Tumbling 26%
Jun 11More Unpleasant Surprises Could Be In Store For Jiangsu Sihuan Bioengineering Co., Ltd's (SZSE:000518) Shares After Tumbling 26%
Apr 17Jiangsu Sihuan Bioengineering Co., Ltd (SZSE:000518) Investors Are Less Pessimistic Than Expected
Feb 26Shareholder Returns
| 000518 | CN Biotechs | CN Market | |
|---|---|---|---|
| 7D | 12.0% | -0.8% | -0.9% |
| 1Y | -18.8% | -17.3% | 5.4% |
Return vs Industry: 000518 underperformed the CN Biotechs industry which returned -17.3% over the past year.
Return vs Market: 000518 underperformed the CN Market which returned 5.4% over the past year.
Price Volatility
| 000518 volatility | |
|---|---|
| 000518 Average Weekly Movement | 10.0% |
| Biotechs Industry Average Movement | 8.8% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.6% |
Stable Share Price: 000518 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 000518's weekly volatility (10%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1992 | 282 | Yu Guo | www.000518shsw.com/shsw |
Jiangsu Sihuan Bioengineering Co., Ltd. engages in the pharmaceutical business in China. It offers delusen, an anti-tumor biotherapeutic drug for the treatment of kidney cancer, malignant melanoma, and cancerous chest and abdominal mass; Xinde Lusheng; Xin Lisheng; and Ring BO. It also engages in breeding and sales of flowers and seedlings; and landscaping projects.
Jiangsu Sihuan Bioengineering Co., Ltd Fundamentals Summary
| 000518 fundamental statistics | |
|---|---|
| Market cap | CN¥3.48b |
| Earnings (TTM) | -CN¥46.57m |
| Revenue (TTM) | CN¥211.48m |
16.4x
P/S Ratio-74.5x
P/E RatioIs 000518 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 000518 income statement (TTM) | |
|---|---|
| Revenue | CN¥211.48m |
| Cost of Revenue | CN¥84.47m |
| Gross Profit | CN¥127.01m |
| Other Expenses | CN¥173.58m |
| Earnings | -CN¥46.57m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.045 |
| Gross Margin | 60.06% |
| Net Profit Margin | -22.02% |
| Debt/Equity Ratio | 3.1% |
How did 000518 perform over the long term?
See historical performance and comparison